SynBioBeta Speaker

Mikah Coffindaffer

Procter & Gamble

R&D Director

I’m a passionate innovator and Research & Development Director with 15 years in the CPG sector, driven by a profound belief in the power of biology to solve unmet consumer needs. My journey has taken me from the vast landscapes of traditional big business, including iconic brands like Head & Shoulders and Secret/Old Spice, to the agile world of developing new brands and acquisitions such as Each & Every and Native.My deep dive into entrepreneurial ventures began as an R&D co-founder during a Lean startup experiment at P&G, where I had the privilege of incubating and scaling a brand from its nascent stages. This experience honed my skills in navigating complex organizations and fostering cross-functional partnerships. I thrive on creating strategies that address critical consumer gaps; for example, delivering aluminum-free deodorants with comparable odor protection through extensive technological exploration and consumer testing.My dedication to leveraging biological insights recently culminated in the launch of Native’s groundbreaking Sensitive Series. Co-created with allergists, dermatologists, and biologists, this product line features precision fermentation-derived ceramides. This advanced application of synthetic biology allows us to harness biological processes to produce high-performance products with exceptional purity and sustainability, significantly benefiting sensitive skin. This project underscores my commitment to integrating cutting-edge life sciences into consumer products that genuinely make a difference.I am deeply invested in life sciences and biology, continually seeking to understand and harness biological mechanisms for consumer benefit. My key strengths lie in front-end innovation, consumer research, and venture partnerships, all underpinned by strong life science expertise and lean innovation principles. I find immense satisfaction in problem-solving and leading with influence, convinced that synthetic biology will increasingly shape the future of CPG.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Sessions Featuring

Mikah

This Year

TBD

Session lineup still growing

Purchase Pass

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Purchase Pass

Featuring

Speaker Coming Soon

Previous Speakers Include